logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Linezolid CAS 165800-03-3

Linezolid CAS 165800-03-3

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 165800-03-3

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15DAY

Payment Terms: L/C,D/A,D/P,T/T,Western Union,MoneyGram

Supply Ability: G,KG,TON

Get Best Price
Highlight:
Appearance::
White Solid
CAS NO::
165800-03-3
Molecular Formula::
C16H20FN3O4
Molecular Weight::
337.34600
EINECS NO::
605-416-1
MDL NO::
MFCD00937825
Appearance::
White Solid
CAS NO::
165800-03-3
Molecular Formula::
C16H20FN3O4
Molecular Weight::
337.34600
EINECS NO::
605-416-1
MDL NO::
MFCD00937825
Linezolid CAS 165800-03-3

Product Description:

Product Name: Linezolid CAS NO: 165800-03-3


Synonyms:

Zyvoxam;

Zyvoxid;

N-[[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;


Chemical & Physical Properties:

Appearance: White solid

Assay :≥99.00%

Density: 1.302 g/cm3

Boiling Point: 585.5℃ at 760 mmHg

Melting Point: 176-178℃

Flash Point: 307.9℃

Refractive Index: 1.553

Storage Condition: Store in original container in a cool dark place.

Vapor Pressure: 1.08E-13mmHg at 25℃


Safety Information:

Safety Statement: S36

HS Code: 2934999090

Risk Statements: R20/21/22

Hazard Code: Xn

Caution Statement: P314

Signal Word: Danger

Symbol: GHS08

Hazard Declaration: H372


Prototype of the oxazolidinone antimicrobials; inhibits bacterial mRNA translation. For the treatment of infections caused by Gram-positive (G+) cocci, including complicating bacteremia; Nosocomial acquired pneumonia; Community acquired pneumonia (pneumonia is clinically divided into hospital acquired pneumonia and community acquired Chemicalbook pneumonia due to the difference of pathogenic bacteria). And accompanying bacteremia; Complex skin and skin soft tissue infections, including diabetic foot infections complicated with osteomyelitis; Uncomplicated skin and skin soft tissue infections; To treat infections caused by vancomycin-resistant Enterococcus faecium.


If you are interested in our products or have any questions, please feel free to contact us!


Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.